Capital Performance Advisors’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-32
Closed -$224 194
2024
Q3
$224 Buy
+32
New +$224 ﹤0.01% 2529